J&J earnings preview: Wall Street is still optimistic despite company’s legal issues

Johnson & Johnson is scheduled to report second-quarter earnings before the market open on Tuesday. Most recent news about J&J (JNJ)  has been about its legal problems, but some analysts still think the future is bright for the baby-powder maker, thanks to a highly diversified slate of products spanning consumer health, pharmaceuticals and medical devices.